Exact FDA event identifier

Event 81466

1 recalled-product record grouped only because every row carries this exact official event ID.

Event summary

Timeline bucket: October 31, 2018
Product types: Drug
Classifications: Class II
Statuses: Terminated
Recalling firm wording: Avella of Deer Valley, Inc. Store 38

Dossier provenance

Source snapshots represented here

openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Device root-cause evidence is not applicable to this event. No grouped product has the official product type device; this is not an unavailable-enrichment finding.

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

BEVACIZUMAB 2.5 MG/0.1ML, pre-filled syringe (deliverable dose of 1.25MG in normject syringe) Repackaged by Avella Specialty Pharmacy, 24416 N 19th Avenue, Pheonix, AZ 85085. NDC 42852-001-24

D-0224-2019

Recall number: D-0224-2019
Initiated: October 31, 2018
Classification: Class II
Status: Terminated
Recalling firm: Avella of Deer Valley, Inc. Store 38
Quantity: 911 syringes

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

Lot # 138-20182408@58 BUD 12/22/2018

Distribution pattern

Product was distributed throughout the United States.